Ergoteles LLC Arvinas, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$36.01 - $74.24 $303,852 - $626,437	-8,438 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$60.27 - $81.57 $508,558 - $688,287	8,438 New	8,438 $568,000
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $408,269 - $596,502	-6,200 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $453,840 - $668,794	6,200 New	6,200 $510,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.